Antibodies to glutamic acid decarboxylase in Syrian and Jordanian type 1 diabetes patients and their siblings

Annals of Saudi Medicine

Volumn 23, Issue 6, 2003, Pages 376-380

  El Khateeb, Mohammed S ^a   Mesri, Shadwan ^a   Juma, Muhieddin ^a   El Zaheri, Mohamed ^a   Ajlouni, Kamel ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Anti GAD; Glutamic acid decarboxylase; Jordan; Syria; Type 1 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; GLUTAMATE DECARBOXYLASE ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREQUENCY ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JORDAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; SCHOOL CHILD; SIBLING; STATISTICAL SIGNIFICANCE; SYRIAN ARAB REPUBLIC;

EID: 0346270717     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.376     Document Type: Article

References (33)

1. Athinson Ma, Maclaren NK. Mechanisms of disease : The pathogenesis of insulin-dependent diabetes mellitus. N Eng J Med. 1994;331:1428.
2. Bach JF. Insulin dependent diabetes mellitus as an autoimmune disease. Endocrinol Rev. 1994;15:516-42.
3. Nepom GT. Immunogenetics and IDDM. Diabetes Rev. 1993;1:93-103.
4. Rossini AA, Greniner DL, Friedman HP, Mordes JP. Immunopathogenesis of diabetes mellitus. Diabetes Rev 1993; 1:43-7.
5. Bottazzo GF. On the honey disease a dialogue with Socrates. Diabetes Rev. 1993;42:778-800.
6. Bonifacio E. Where are the T cells? A friendly provocation. J Endocrinal Invest. 1994;17:560-562.
7. Scherbaum WA. Etiology and pathogenesis of Type 1 diabetes. Horm Metab Res. 1992;26:111-6.
8. Lernmark A, Freedman ZR, Hofmann C et al. Islet cell surface antibodies in juvenile diabetes mellitus. N Eng J Med. 1978;299:375-80.
9. Plamer JD, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science. 1983;222:1337-1339.
10. Athinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ. 64,000 Ms autoantibodies as predictors of insulin-dependent diabetes. Lancet. 1990;335:1357-1360.
11. Hagopian WA, Karlsen AE, Gottsater A et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 65K autoantibody positivity at onset predicts diabetes type. J Clin Invest. 1993;91:368-374.
12. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacion E, Bottazzo GF. Antibodies to islet 37K antigen, but not to glutamate decarboxylase discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes. 1994;43:1254-1259.
13. Maclaren NH. How, when and why to predict IDDM. Diabetes. 1988;37:1591-1594.
14. Serjeantson S, Court J, Mackay IR et al. HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin dependent diabetes mellitus patients. Hum Immunol. 1993;38:97-104.
15. Chen QY, Rowley MJ, Byrne GC, Jones TW, Tuomi T, Knowles WJ, Zimmet PZ, Macay IR. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first degree relatives. Pediatr Res. 1993;34:785-790.
16. Myers MA, Rabin DU, Rowley MJ. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes. 1995;44(11):1290-5.
17. Serrano-Rios M, Gutierreztopez-Lopez MD, Perez-Bravo F, Martinez MT, Antona J, Rowley M, Mackay I, Zimmet P. HLA DR, DQ and anti-GAD antibodies in first degree relatives of Type 1 diabetes mellitus. Diabetes Res Clin Pract. 1996;34:133-139.
18. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M, Hulinska H, Hulinska I, Silvestrini RA, Kamath S, Sharp A, Arundel T, Silin KM. Antiglutamate decarboxylase and other antibodies at the onset of childhood IDDM: A population-based study. Diabetologia. 1994;37(11):1113-1120.
19. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkrist G, Dahlquist G, Palmer J, Larnmark A. Glutamate decarboxyylas-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest. 1995:1505-1511.
20. Schott M, Schatz D, Atkinson M, Krischer J, Mehta H, Vold B, Maclaren N. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes. J Autoimmun. 1994;7(6):865-872.
21. Bingley PJ, Bonifacio E, Shattock M et al. Can islet cell antibodies predict IDDM in the general population. Diabetes Care. 1993;16:45-50.
22. Samuelsson U, Sundkvist G, Borg H, Fernlund P, Ludvigsson L. Islet autoantibodies in the prediction of diabetes in school children. Diabetes Res Pract. 2001;15(1):51-57.
23. Lernmark A. Molecular biology of IDDM. Diabetologia. 1994;37(2):73-81.
24. Tsurvoka A, Matsaba I, Toyota T, Issika G, Nagataki S, Ikeda Y. Antibodies to GAD in Japanese diabetic patients: A multicenter study. Diabetes Res Clin Pract. 1995;85(3):191-199.
25. Tuomi T, Zimmet P, Rowley MJ, Min HK, Vichayanrat A, Lee HK, Rhee BD, Vannasaeng S, Humphrey AR, Mackay IR. Differing frequency of autoantibodies to glutamic decarboxylase among Korans, Thais, and Australians with diabetes mellitus. Clin Immunol Immunopathol. 1995;32(2):202-206.
26. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contribution to susceptibility and resistance to insulin dependent diabetes mellitus. Nature. 1987;329:599-604.
27. Buzzetti R, Nistico L, Osborn J, Giovanni C, Chersi A, Sorrentino R. HLA-DQA1 and DQB1 gene polymorphisms in Type 1 diabetic patients from central Italy and their use for risk prediction. Diabetes. 1993;42:1173-8.
28. Tuomilehto J, Zimmet P, Mackay LR, Koskela P, Vidgewn G, Toivanen L, Tuomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ. Antibodies to glutamic acid decarboxylase as predictors of insulin dependent diabetes mellitus before clinical onset of disease. Lancet. 1994;43:1383-1385.
29. Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women. Diabet Med. 1997;14(8):678-685.
30. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knwoles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoiimune diabetes mellitus in adults with a non-insulin dependent onset of disease. Diabetes. 1993;42:359-362.
31. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, cohen M. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Med. 1994;11:299-303.
32. Landin-Olsson M, Ostman J, Lernmark A, Nystrom L, Schersten B, and the DISS group. ICA, GAD65-AB and C-peptide in the differential diagnosis of diabetes type in young adults. Diabetologia. 1993;36(1):A99.
33. Thai AC, Ng WY, Loke KY, Lee WR, Lui KF, Cheah JS. Anti-GAD antibodies in Chinese patients with young and adult onset IDDM and NIDDM. Diabetologia. 1997;115(16):1425-1430.